about
Mesenchymal stem cells avoid allogeneic rejectionExpression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complexesCatecholamine-induced interleukin-10 release: a key mechanism in systemic immunodepression after brain injurySuppression of granulocyte/macrophage colony-stimulating factor release from human monocytes by cyclic AMP-elevating drugs: role of interleukin-10Effects of cytokine milieu secreted by BCG-treated dendritic cells on allergen-specific Th immune response.Cytokines in asthma.Interleukin-10: an anti-inflammatory cytokine with therapeutic potential.Anti-IL5 decreases the number of eosinophils but not the severity of dermatitis in Sharpin-deficient miceTherapeutic strategies for allergic diseases.Alternative strategies in the treatment of bronchial asthma.Endogenous inhibitory mechanisms in asthma.Mechanisms of allergen-specific immunotherapy.New perspectives in asthma treatment.Novel therapy for asthma.Inhibitory effects of interleukin-10 plasmid DNA on the development of atopic dermatitis-like skin lesions in NC/Nga mice.Immune responses during allergic sensitization and the development of atopy.Chlamydia pneumoniae and severity of asthma.Mechanisms of interleukin-10-mediated immune suppression.Molecular mechanisms of atopyDecreased prevalence of asthma among children with high exposure to cat allergen: relevance of the modified Th2 responseNovel therapies for the treatment of inflammatory airway disease.Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's diseaseAsthma refractory to glucocorticoids: the role of newer immunosuppressants.IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitizationNew anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease.The cytokine network in asthma and chronic obstructive pulmonary diseasePathophysiology of allergic inflammation.The immunopharmacology of skin inflammation: the future is already here!Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease.TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand.The failure of interleukin-10-deficient mice to develop airway hyperresponsiveness is overcome by respiratory syncytial virus infection in allergen-sensitized/challenged mice.Endogenous IL-10 regulates IFN-gamma and IL-5 cytokine production and the granulomatous response in Schistosomiasis mansoni-infected mice.Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model.Macrophage and microglial responses to cytokines in vitro: phagocytic activity, proteolytic enzyme release, and free radical production.Cytokine responses correlate differentially with age in infancy and early childhood.Effect of waterpipe tobacco smoking on airway inflammation in murine model of asthma.Complementary usage of Rhodiola crenulata (L.) in chronic obstructive pulmonary disease patients: the effects on cytokines and T cells.Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed miceAssociation of Elevated Serum GM-CSF, IFN-, IL-4, and TNF- Concentration with Tobacco Smoke Induced Chronic Obstructive Pulmonary Disease in a South Indian Population
P2860
Q21245658-E2DFFCCA-E24D-4171-89CC-7272F92EBF75Q24671876-CFD12AAB-CED8-4354-B850-20EA08B7B46BQ24795412-DEF009F8-9899-401A-9B3F-4D669F4F89AEQ28346712-0CC6B1B3-4446-44A1-A7A8-363971A423D0Q33629640-5C91F419-F183-4CF2-A17F-67EA45F1F87DQ33717312-38CEA68C-8EF5-466C-972A-A66D4BB874A1Q33723684-B63E5B78-75A0-45CA-AE25-AE00D41DFF6EQ33780705-13775564-D138-4F07-99F3-31EA19A7DD02Q33787614-B7CE6419-4785-4C0E-BF1E-A253967FB348Q33801225-1E17DE7A-8509-4C7F-9782-18EA3F3B92C7Q33860266-CF8F804E-3660-40A7-BC14-3958D566F469Q33945896-CF767D3A-E5E4-42BF-BABE-EC0B906CEC91Q33987222-9A51CDBE-44BB-4FA9-988A-3DFD2059688BQ34074657-3DFF8757-4BE7-4436-A82E-6836B4348281Q34075763-DC4B0BCA-E2D0-4CF3-90F3-3C01776007FEQ34093046-BCDF40D4-10FC-45B6-AB5F-63300D4E6E87Q34116681-CA27A5EA-9103-4BB3-B3B7-260216A358D7Q34285968-97354575-83B7-4DEE-8FD6-737E7914D13FQ34510796-CDD4783F-1A7D-483A-B6DA-D83BBB551615Q34510803-162F8057-B701-4BF0-B38F-7DD72C50094EQ35040779-359D80AD-6CB7-432E-9FBB-0FA1BF6FBC52Q35364265-0D401171-73FC-466F-A58D-485FCD399A3DQ35627919-079AA4E5-55DA-493A-91D1-5FF7B0F91545Q35757072-54AB326A-C353-4C2C-B1A7-EA8732852513Q35842492-27421A73-DD99-4518-B31C-E18E4555BA24Q36955575-14DB4DED-11F7-48BB-9197-062E9AFCB7E5Q37891126-F11FFB17-399B-47B0-9CAC-83FCEC549527Q40756377-1D602389-182D-4FFC-87ED-0A38A6358FC3Q40932149-9A993F73-A300-4A77-9B3D-C17D7800515BQ42972510-F9E42D78-3911-4494-845E-3B027D43D97CQ43442877-1EA074BF-D955-46B4-9A62-3D88CE4AF15DQ43826283-0B8A5BA6-BA31-4E04-9232-807EA4A70FC0Q43854219-06DE3BC5-ABFC-4B9A-848A-09BFF5179FAAQ46333503-99C87F27-626C-44F9-B85C-E6D0D849B14DQ46811055-952ED11F-686A-461B-9A31-CAA1FC0049D2Q51090544-568121AD-1A05-4DE4-94D7-BE53F242134CQ53003648-A318D85E-7460-4540-B29A-27716364B399Q56904615-450210CC-5D4A-4F7F-8F0A-A070C4AF0A35Q58805864-D7200BCA-77BB-4B8B-8A77-B87436416F63
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
IL-10: a potential therapy for allergic inflammation?
@en
type
label
IL-10: a potential therapy for allergic inflammation?
@en
prefLabel
IL-10: a potential therapy for allergic inflammation?
@en
P1433
P1476
IL-10: a potential therapy for allergic inflammation?
@en
P2093
Pretolani M
P304
P356
10.1016/S0167-5699(97)80023-0
P577
1997-06-01T00:00:00Z